| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 05/29/2013 | CN103120769A Medicine for treating cerebral circulation insufficiency |
| 05/29/2013 | CN103120768A Medicament for treating vital myocarditis and cardiomyopathy |
| 05/29/2013 | CN103120767A Traditional Chinese medicine for treating diabetic retinopathy and preparation method thereof |
| 05/29/2013 | CN103120766A Traditional Chinese medicine composition for treating hypertension |
| 05/29/2013 | CN103120764A Traditional Chinese medicine for relieving cerebral circulation insufficiency |
| 05/29/2013 | CN103120763A Medicinal composition for treating sequela of cerebral apoplexy |
| 05/29/2013 | CN103120747A Drug for treating vital myocarditis |
| 05/29/2013 | CN103120738A Medicinal composition for treating ischemic cerebral apoplexy |
| 05/29/2013 | CN103120736A Method for preparing medicinal preparation for treating apoplexy hemiplegia |
| 05/29/2013 | CN103120735A Medicinal composition for treating cerebral apoplexy hemiplegia |
| 05/29/2013 | CN103120733A Medicine for treating myocarditis |
| 05/29/2013 | CN103120724A Medicine for treating myocardial ischemia |
| 05/29/2013 | CN103120709A Medicinal composition for treating cerebrovascular disease |
| 05/29/2013 | CN103120706A Method for preparing high-purity rutin via two-dimensional liquid chromatography-mass spectrometry combined technology |
| 05/29/2013 | CN103120675A Application of Eryngiolide A in medicine for treating atherosclerosis |
| 05/29/2013 | CN103120670A Application of Eryngiolide A in medicine for treating or preventing acute heart failure |
| 05/29/2013 | CN103120663A Application of Eryngiolide A in vascular dilation drug |
| 05/29/2013 | CN103120656A Danshinolic acid A tablet and application thereof for preparing medicines |
| 05/29/2013 | CN103120651A Manidipine tablet |
| 05/29/2013 | CN103120641A Graphene oxide supported benazepril compound as well as preparation method and application thereof |
| 05/29/2013 | CN103120509A Drug pillow |
| 05/29/2013 | CN102657658B Medicine composition for treating myocardial infarction, vascular circulatory disturbance and thrombosis |
| 05/29/2013 | CN102626390B Gastrodin multiphase liposome injection |
| 05/29/2013 | CN102600173B Amlodipine/benazepril medicament composition liposome solid preparation |
| 05/29/2013 | CN102552811B Oral Chinese medicine composition for treating apoplexy |
| 05/29/2013 | CN102526613B Medicament for treating allergic cutaneous vasculitis |
| 05/29/2013 | CN102526470B Medicinal composition for treating primary hypertension |
| 05/29/2013 | CN102492594B Bamboo juice wine and preparation method thereof |
| 05/29/2013 | CN102485218B Clopidogrel hydrogen sulfate tablet and preparation method thereof |
| 05/29/2013 | CN102406595B Floating microorganism adhesive porous hydrogel and preparation method thereof |
| 05/29/2013 | CN102397287B Application of opuntia ficus-indica polysaccharide in preparation of medicine with hypolipidemic effect |
| 05/29/2013 | CN102397286B Application of prickly pear polysaccharide in preparation of medicament or health-care product with hypoglycemic effect |
| 05/29/2013 | CN102380011B Traditional Chinese medicine composition for treating polyarteritis nodosa |
| 05/29/2013 | CN102370648B Medicinal composition and its application |
| 05/29/2013 | CN102366410B Argatroban liposome injection |
| 05/29/2013 | CN102302765B Herba sarcandrae, rhizoma cibotii, suberect spatholobus stem and muskroot-like semiaquilegia root powder for treating lower extremity varicose veins |
| 05/29/2013 | CN102125559B Pharmaceutical composition containing pentoxifylline and carbazochrome sodium sulfonate and application thereof |
| 05/29/2013 | CN102038644B Lutein water-soluble powder and preparation process thereof |
| 05/29/2013 | CN102037124B hERG mutants and uses thereof |
| 05/29/2013 | CN102026664B Composition for stabilizing Beta-blocker, and transdermally absorbable preparation comprising the composition |
| 05/29/2013 | CN101978054B Monoclonal antibody capable of binding to heparin-binding epidermal growth factor-like growth factor |
| 05/29/2013 | CN101889953B Device and method for manufacturing drug smoke liquid and drug smoke |
| 05/29/2013 | CN101856398B Detection method of Chinese medicinal composition for clearing heat and cooling blood, promoting blood circulation and stopping pain |
| 05/29/2013 | CN101851247B Composition containing clopidogrel bisulfate crystal particles |
| 05/29/2013 | CN101815525B Anti-hypertensive agent |
| 05/29/2013 | CN101693714B Spirocyclic cyclohexane derivatives |
| 05/29/2013 | CN101553491B Quinoxaline derivative |
| 05/29/2013 | CN101538218B Pharmaceutical composition for treating or preventing degenerative and inflammatory diseases |
| 05/29/2013 | CN101434593B Two crystal substances of baicalin, and preparations, pharmaceutical composition and uses thereof |
| 05/29/2013 | CN101429185B Two-crystal type of substance of meletin, production method, medicament composition and uses thereof |
| 05/29/2013 | CN101225424B Single-glucopyranoside of cyclomembranousol, preparation method, medicament combination and uses thereof |
| 05/28/2013 | US8450470 Use to faciliate drug delivery of other drugs, or treat glycosaminoglycan associated pathologies, such as scarring, spinal cord injury, glaucoma, and cosmetic treatments |
| 05/28/2013 | US8450371 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs |
| 05/28/2013 | US8450329 Benzoxazole kinase inhibitors and methods of use |
| 05/28/2013 | US8450325 Methods for reducing the recurrence of cardiac arrhythmia |
| 05/28/2013 | US8450288 For introduction of a disc prosthesis or implant; involves providing substance(s) beneficial to the intervertebral disc through a cannulated element |
| 05/28/2013 | CA2716352C Conformationally constrained carboxylic acid derivatives useful for treating metabolic disorders |
| 05/28/2013 | CA2714295C Desaturase genes, enzymes encoded thereby, and uses thereof |
| 05/28/2013 | CA2685447C Pharmaceutical composition |
| 05/28/2013 | CA2604797C New tricyclic angiotensin ii agonists |
| 05/28/2013 | CA2565630C Pyrrolidin-2-one and piperidin-2-one derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 05/28/2013 | CA2563260C Methods of treating autoimmune and inflammatory diseases |
| 05/28/2013 | CA2547887C Protein modifier production inhibitor |
| 05/28/2013 | CA2485346C Human adam-10 inhibitors |
| 05/28/2013 | CA2476773C Monoclonal antibodies against extracellular loops of c5ar |
| 05/28/2013 | CA2464353C Linear basic compounds having nk-2 antagonist activity and formulations thereof |
| 05/28/2013 | CA2453301C Synthetic double-stranded oligonucleotides for specific inhibition of gene expression |
| 05/23/2013 | WO2013073602A1 Nucleic acid fragment binding to target protein |
| 05/23/2013 | WO2013072767A1 Compositions and preconcentrates comprising at least one salicylate and omega-3 fatty acid oil mixture |
| 05/23/2013 | WO2013072714A1 Antibodies for molecular imaging of vulnerable plaques in atherosclerosis |
| 05/23/2013 | WO2013072694A1 Thieno- and furo - pyrimidines and pyridines, useful as potassium channel inhibitors |
| 05/23/2013 | WO2013072693A1 Thieno [2, 3 - c] pyrazoles for use as potassium channel inhibitors |
| 05/23/2013 | WO2013072573A1 Products for oral administration comprising extracts of punica granatum (pomegranate), intended for a pet, and applications of same |
| 05/23/2013 | WO2013072514A1 Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or anti-adm non-ig scaffold for regulating the fluid balance in a patient having a chronic or acute disease |
| 05/23/2013 | WO2013072513A1 Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or anti-adm non-ig scaffold for use in therapy of an acute disease or acute condition of a patient for stabilizing the circulation |
| 05/23/2013 | WO2013072512A1 Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or an anti-adm non-ig scaffold for use in therapy |
| 05/23/2013 | WO2013072511A1 Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or anti-adm non-ig scaffold for prevention or reduction of organ dysfunction or organ failure in a patient having a chronic or acute disease or acute condition |
| 05/23/2013 | WO2013072510A1 Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or anti-adm non-ig scaffold for reducing the risk of mortality in a patient having a chronic or acute disease or acute condition |
| 05/23/2013 | WO2013072438A1 Antibodies for molecular imaging of vulnerable plaques in atherosclerosis |
| 05/23/2013 | WO2013072328A1 Use of telaprevir and related compounds in atherosclerosis, heart failure, renal diseases, liver diseases or inflammatory diseases |
| 05/23/2013 | WO2013072327A1 Use of boceprevir and related compounds in atherosclerosis, heart failure, renal diseases, liver diseases or inflammatory diseases |
| 05/23/2013 | WO2013071697A1 Aminoquinazoline derivatives and their salts and methods of use |
| 05/23/2013 | WO2013049591A3 Dual inhibitor compounds and methods of use thereof |
| 05/23/2013 | WO2013048989A3 Pyrazole compounds |
| 05/23/2013 | WO2013048158A3 Novel usage for eupatilin |
| 05/23/2013 | US20130131125 Therapeutic combination |
| 05/23/2013 | US20130131071 Use of pteridine derivatives for the treatment of increased intracranial pressure, secondary ischemia, and disorders associated with an increased level of cytotoxic reactive oxygen species |
| 05/23/2013 | US20130131026 Compositions and methods for treating symptoms of inflammatory related conditions using a combination of an antihistamine and a stimulant |
| 05/23/2013 | US20130129717 Monoclonal Antibodies Against Extracellular Loops of C5aR |
| 05/23/2013 | US20130129680 Method for treating hepatitis c virus infection using quercetin-containing compositions |
| 05/23/2013 | CA2856288A1 Nucleic acid fragment binding to target protein |
| 05/23/2013 | CA2856229A1 Methods of treatment with deferiprone |
| 05/23/2013 | CA2856154A1 Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or anti-adm non-ig scaffold for prevention or reduction of organ dysfunction or organ failure in a patient having a chronic or acute disease or acute_condition |
| 05/23/2013 | CA2856150A1 Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or anti-adm non-ig scaffold for regulating the fluid balance in a patient having a chronic or acute disease |
| 05/23/2013 | CA2856142A1 Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or anti-adm non-ig scaffold for use in therapy of an acute disease or acute condition of a patient for stabilizingthe circulation |
| 05/23/2013 | CA2856141A1 Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or an anti-adm non-ig scaffold for use in therapy |
| 05/23/2013 | CA2856136A1 Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or anti-adm non-ig scaffold for reducing the risk of mortality in a patient having a chronic or acute disease or acute condition |
| 05/23/2013 | CA2856030A1 Bisphosphonate compositions and methods for treating and/or reducing cardiac dysfunction |
| 05/23/2013 | CA2855346A1 Thieno- and furo - pyrimidines and pyridines, useful as potassium channel inhibitors |
| 05/23/2013 | CA2853883A1 Antibodies for molecular imaging of vulnerable plaques in atherosclerosis |